Completed NA INTERVENTIONAL 2-arm NCT01854138

Evaluating Advantages of Prevena After Hip and Knee Arthroplasty

Evaluating the Efficacy of the Prevena Incision Management System in Patients Undergoing Total Knee and Hip Arthroplasty

Sponsor: ProMedica Health System

Conditions Infection of Total Hip Joint Prosthesis

Interventions Prevena Incision Management System

Updated 9 times since 2017 Last updated: Jun 11, 2018 Started: Jan 31, 2014 Primary completion: Mar 31, 2015 Completion: Apr 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Infection of Total Hip Joint Prosthesis and is currently completed. ProMedica Health System leads this study, which shows 9 recorded versions since 2014 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Jan 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 4 earlier versions

Aug 2018 — Jan 2021 [monthly]

Completed NA

Phase: PHASE4 → NA
Jun 2018 — Aug 2018 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ProMedica Health System

Data source: ProMedica Health System

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toledo, United States